Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Typhoid Fever – A race against time

16.01.2014
The life-threatening disease typhoid fever results from the ongoing battle between the bacterial pathogen Salmonella and the immune cells of the body.

Prof. Dirk Bumann’s research group at the Biozentrum of the University of Basel has now uncovered how the typhoid pathogen repeatedly manages to evade the host’s immune system. Their findings are published in the scientific journal “Cell Host & Microbe”.


Salmonella-infected cells (macrophages in blue, monocytes in turquoise). Dead Salmonella (only yellow), surviving Salmonella (yellow and red).

Illustration: University of Basel

Typhoid fever is a bacterial infection caused by the pathogen Salmonella. The infected host’s immune system detects Salmonella and activates immune cells such as neutrophils and monocytes. These cells infiltrate the infected tissue and enclose the infection to form an abscess. Although most Salmonella bacteria are readily killed by this immune reaction, Dirk Bumann’s group has demonstrated that some escape from the abscess and thus ensure their survival.

Salmonella uses immune cells

Once outside the abscess, the Salmonella bacteria are attacked by other immune cells, the so-called macrophages that produce a less effective immune response. “Salmonella have developed a range of defense strategies to resist macrophage attacks. Many Salmonella are thus able to survive and even to replicate in macrophages,” explains Neil Burton, one of the two first authors. With time, abscesses form around the new infection foci but again some Salmonella bacteria can manage to escape.

“This drives the whole infection process further and makes typhoid fever particularly insidious,” says Nura Schürmann, also a first author of the publication.

A battle on many fronts

The whole disease process is a race between Salmonella and the immune system of the infected organism, in which the battle is fought on many fronts. In this process many Salmonella bacteria are killed and others survive to spread the infection. It is the net balance of the outcomes of these individual Salmonella and immune cell encounters which in the end determines the course of the illness.

Typhoid fever is a life-threatening infection in countries with poor hygiene. Each year, more than 20 million people are infected with this disease. The illness is transmitted by ingesting food or water contaminated with this bacterium. Once inside the intestine, Salmonella crosses the gut mucosa and spreads to other organs such as the spleen and liver. Growing antibiotic resistance makes this illness increasingly difficult to cure.

Understanding what factors enable Salmonella to win many encounters with host cells might provide new strategies in the treatment of typhoid fever. Similar heterogeneous encounters likely determine the fights between the host and many other pathogens. Findings of this study may thus be relevant for a wide range of infectious diseases.

Original Citation
Neil A. Burton, Nura Schürmann, Olivier Casse, Anne K. Steeb, Beatrice Claudi, Janine Zankl, Alexander Schmidt, Dirk Bumann
Disparate Impact of Oxidative Host Defenses Determines the Fate of Salmonella during Systemic Infection in Mice
Cell Host & Microbe, Volume 15, Issue 1, 72-83, 15 January 2014 |
doi: 10.1016/j.chom.2013.12.006
Further Information
Prof. Dr. Dirk Bumann, University of Basel, Biozentrum,
phone: +41 61 267 23 82, Email: dirk.bumann@unibas.ch

Olivia Poisson | Universität Basel
Further information:
http://www.unibas.ch
http://unibas.ch/index.cfm?uuid=8B97DAF7F3F274D35D46A5758BA461CC&type=search&show_long=1&&o_lang_id=2

Further reports about: Biozentrum Salmonella immune cell immune system typhoid typhoid fever

More articles from Life Sciences:

nachricht Subcutaneous Administration of Multispecific Antibody Makes Tumor Treatment Faster & More Tolerable
01.07.2015 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Why human egg cells don't age well
01.07.2015 | RIKEN

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Viaducts with wind turbines, the new renewable energy source

Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.

The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...

Im Focus: X-rays and electrons join forces to map catalytic reactions in real-time

New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions

A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...

Im Focus: Iron: A biological element?

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...

Im Focus: Thousands of Droplets for Diagnostics

Researchers develop new method enabling DNA molecules to be counted in just 30 minutes

A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...

Im Focus: Bionic eye clinical trial results show long-term safety, efficacy vision-restoring implant

Patients using Argus II experienced significant improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference on Regenerative Medicine in Leipzig: Last chance to submit abstracts until 2 July

25.06.2015 | Event News

World Conference on Regenerative Medicine: Abstract Submission has been extended to 24 June

16.06.2015 | Event News

MUSE hosting Europe’s largest science communication conference

11.06.2015 | Event News

 
Latest News

Siemens acquires leading UK enforcement provider Zenco Systems

02.07.2015 | Press release

Viaducts with wind turbines, the new renewable energy source

02.07.2015 | Power and Electrical Engineering

NASA sees heavy rain in Tropical Cyclone Chan-Hom

02.07.2015 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>